at MarketWatch.com (Jan 2, 2013)
OncoGenex Pharmaceuticals (OGXI +7.6%) falls 12.3% AH after filing for a stock offering featuring an undisclosed number of shares. The company plans to partly use the proceeds to develop its OGX-427 cancer drug, and possibly other drug candidates.
From other sites
at MarketWatch.com (Mar 16, 2012)
at MarketWatch.com (Jun 21, 2010)